These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 6874387

  • 21. Severe hypertension in childhood due to prolonged skin application of a mineralocorticoid ointment.
    Bartorelli A, Rimondini A.
    Hypertension; 1984; 6(4):586-8. PubMed ID: 6746088
    [Abstract] [Full Text] [Related]

  • 22. [Exogenous mineralocorticoid hypertension: pathogenetic and clinical considerations].
    Armanini D.
    G Clin Med; 1990; 71(8-9):483-92. PubMed ID: 2279623
    [No Abstract] [Full Text] [Related]

  • 23. [Severe hypopotassemia and rhabdomyolysis in a normotensive subject after use of a nasal spray containing 9-alpha-fluoroprednisolone].
    Wu SC, Secchi MB, Mancarella S, Oltrona L, Bettazzi L, Sale M, Ambrosi B.
    Recenti Prog Med; 1989 Apr; 80(4):195-6. PubMed ID: 2762657
    [Abstract] [Full Text] [Related]

  • 24. Pseudohyperaldosteronism due to application of an antihemorrhoid cream.
    Marin F, González Quintela A, Moya M, Suárez E, de Zárraga M.
    Nephron; 1989 Apr; 52(3):281-2. PubMed ID: 2739869
    [Abstract] [Full Text] [Related]

  • 25. [Hypertension and hypokalemia caused by a nasal spray containing fluorprednisolone acetate].
    Maiorano G, Loiacono N, Di Bello V, Contursi V, Castelnuovo F, Albano O.
    Boll Soc Ital Cardiol; 1981 Apr; 26(5):465-71. PubMed ID: 7340877
    [No Abstract] [Full Text] [Related]

  • 26. [Hypokalemic myopathy and metabolic alkalosis secondary to the topical application of 9-alpha-fluoroprednisolone].
    Pachón Diaz J, López Cortés L, Navarro Rodríguez A, García Criado F.
    Rev Clin Esp; 1983 Sep 15; 170(5):221-2. PubMed ID: 6647945
    [No Abstract] [Full Text] [Related]

  • 27. [A hypokalemic normotensive variant of the syndrome caused by nasal spray containing 9-alpha-fluoroprednisolone].
    Mammarella A, Barlattani M, Bucci O, Fattori F, Filippello CP, Cugini P, Piernatale L, Letizia C, Murano G.
    Clin Ter; 1985 Jan 15; 112(1):9-19. PubMed ID: 4017454
    [No Abstract] [Full Text] [Related]

  • 28. Exogenous mineralocorticoid-like disorders.
    Mantero F.
    Clin Endocrinol Metab; 1981 Nov 15; 10(3):465-78. PubMed ID: 6178539
    [No Abstract] [Full Text] [Related]

  • 29. [Rhabdomyolysis and arterial hypertension caused by apparent excess of mineralocorticoids: a case report].
    Sardi A, Geda C, Nerici L, Bertello P.
    Ann Ital Med Int; 2002 Nov 15; 17(2):126-9. PubMed ID: 12150047
    [Abstract] [Full Text] [Related]

  • 30. Hypokalaemic hypertension due to a nasal spray containing 9 alpha fluoroprednisolone.
    Zoccali C, Maggiore Q.
    Hum Toxicol; 1984 Jun 15; 3(3):245-7. PubMed ID: 6745965
    [No Abstract] [Full Text] [Related]

  • 31. [Hypopotassemia and rhabdomyolysis. Description of 3 cases of different etiologies].
    Maresca MC, Calconi G, Amici GP, Teodori T, Da Porto A.
    Minerva Med; 1988 Jan 15; 79(1):55-60. PubMed ID: 3340316
    [Abstract] [Full Text] [Related]

  • 32. [Hypokalemic alkalosis due to 9-alpha-fluoroprednisolone locally applied in pemphigus vulgaris].
    Scarpa C, Gentilli G.
    G Ital Dermatol Venereol; 1983 Jan 15; 118(3):179-81. PubMed ID: 6546245
    [No Abstract] [Full Text] [Related]

  • 33. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S, Bernheim J, Podjarny E.
    Isr Med Assoc J; 2002 Jan 15; 4(1):17-20. PubMed ID: 11802302
    [Abstract] [Full Text] [Related]

  • 34. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Rodríguez JA.
    Rev Med Chil; 2000 Jan 15; 128(1):17-26. PubMed ID: 10883518
    [Abstract] [Full Text] [Related]

  • 35. [Hypopotassemic myopathy caused by topical administration of 9 alpha fluoroprednisolone].
    Molins A, Alvarez-Sabín J, Montalbán J, Molero J, Alegre J, Codina A.
    Neurologia; 1987 Jan 15; 2(5):244-6. PubMed ID: 3274232
    [No Abstract] [Full Text] [Related]

  • 36. [Mineralocorticoid-like hypertension. "Apparent mineralocorticoid excess". A hereditary type of hypertension?].
    Christensen TH, Kaae HH, Ibsen H.
    Ugeskr Laeger; 1999 Oct 18; 161(42):5800-3. PubMed ID: 10578695
    [Abstract] [Full Text] [Related]

  • 37. Liquorice-induced sodium retention. Merely an acquired condition of apparent mineralocorticoid excess? A case report.
    Negro A, Rossi E, Regolisti G, Perazzoli F.
    Ann Ital Med Int; 2000 Oct 18; 15(4):296-300. PubMed ID: 11202632
    [Abstract] [Full Text] [Related]

  • 38. [Hypokalemic hypertension cause by licorice abuse].
    Hansen A, Rump LC.
    Dtsch Med Wochenschr; 2007 Nov 18; 132(46):2447-8. PubMed ID: 17987552
    [No Abstract] [Full Text] [Related]

  • 39. Effects of dexamethasone and isoflupredone acetate on plasma potassium concentrations and other biochemical measurements in dairy cows in early lactation.
    Coffer NJ, Frank N, Elliott SB, Young CD, van Amstel SR.
    Am J Vet Res; 2006 Jul 18; 67(7):1244-51. PubMed ID: 16817750
    [Abstract] [Full Text] [Related]

  • 40. [Again on the subject of arterial hypertension caused by the chronic cutaneous application of mineralocorticoids].
    Bisignani G, Boncompagni F, Plastina F.
    Minerva Endocrinol; 1988 Jul 18; 13(1):16. PubMed ID: 3367885
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.